Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2011, Article ID 918916, 5 pages
http://dx.doi.org/10.1155/2011/918916
Review Article

Role of Extracellular Hemoglobin in Thrombosis and Vascular Occlusion in Patients with Sickle Cell Anemia

Thrombosis Research Division, Cardiovascular Research Section, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, N1319, Houston, TX 77030, USA

Received 15 August 2010; Revised 5 November 2010; Accepted 22 November 2010

Academic Editor: Fernando F. Costa

Copyright © 2011 Zhou Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Herrick, “Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia,” Archives of Internal Medicine, vol. 6, no. 5, pp. 517–521, 1910. View at Google Scholar
  2. L. Pauling, H. A. Itano, S. J. Singer, and I. C. Wells, “Sickle cell anemia, a molecular disease,” Science, vol. 110, no. 2865, pp. 543–548, 1949. View at Google Scholar · View at Scopus
  3. V. M. Ingram, “Gene mutations in human hæmoglobin: the chemical difference between normal and sickle cell hæmoglobin,” Nature, vol. 180, no. 4581, pp. 326–328, 1957. View at Publisher · View at Google Scholar · View at Scopus
  4. “WHO report on sickle cell anemia and thalassemia,” 2006.
  5. M. J. Stuart and R. L. Nagel, “Sickle-cell disease,” Lancet, vol. 364, no. 9442, pp. 1343–1360, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. W. A. Eaton and J. Hofrichter, “Hemoglobin S gelation and sickle cell disease,” Blood, vol. 70, no. 5, pp. 1245–1266, 1987. View at Google Scholar · View at Scopus
  7. B. Balkaran, G. Ghar, J. S. Morris, P. W. Thomas, B. E. Serjeant, and G. R. Serjeant, “Stroke in a cohort of patients with homozygous sickle cell disease,” Journal of Pediatrics, vol. 120, no. 3, pp. 360–366, 1992. View at Google Scholar · View at Scopus
  8. W. C. Wang, J. W. Langston, and J. W. Langston, “Abnormalities of the central nervous system in very young children with sickle cell anemia,” Journal of Pediatrics, vol. 132, no. 6, pp. 994–998, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Harlan, “Introduction: anti-adhesion therapy in sickle cell disease,” Blood, vol. 95, no. 2, pp. 365–367, 2000. View at Google Scholar · View at Scopus
  10. R. P. Hebbel, M. A. B. Boogaerts, J. W. Eaton, and M. H. Steinberg, “Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity,” New England Journal of Medicine, vol. 302, no. 18, pp. 992–995, 1980. View at Google Scholar · View at Scopus
  11. N. Mohandas, E. Evans, B. Kukan, and A. Leung, “Sickle erythrocyte adherence to vascular endothelium. Morphology correlates and the requirement for divalent cations and collagen-binding plasma proteins,” Journal of Clinical Investigation, vol. 76, no. 4, pp. 1605–1612, 1985. View at Google Scholar · View at Scopus
  12. D. K. Kaul and M. E. Fabry, “In vivo studies of sickle red blood cells,” Microcirculation, vol. 11, no. 2, pp. 153–165, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Udani, Q. Zen, and Q. Zen, “Basal cell adhesion molecule/lutheran protein: the receptor critical for sickle cell adhesion to laminin,” Journal of Clinical Investigation, vol. 101, no. 11, pp. 2550–2558, 1998. View at Google Scholar · View at Scopus
  14. R. A. Swerlick, J. R. Eckman, A. Kumar, M. Jeitler, and T. M. Wick, “αβ-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium,” Blood, vol. 82, no. 6, pp. 1891–1899, 1993. View at Google Scholar · View at Scopus
  15. K. Sugihara, T. Sugihara, N. Mohandas, and R. P. Hebbel, “Thrombospondin mediates adherence of CD36 sickle reticulocytes to endothelial cells,” Blood, vol. 80, no. 10, pp. 2634–2642, 1992. View at Google Scholar · View at Scopus
  16. C. A. Hillery, M. C. Du, R. R. Montgomery, and J. P. Scott, “Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin,” Blood, vol. 87, no. 11, pp. 4879–4886, 1996. View at Google Scholar · View at Scopus
  17. D. D. Roberts, S. B. Williams, H. R. Gralnick, and V. Ginsburg, “von Willebrand factor binds specifically to sulfated glycolipids,” Journal of Biological Chemistry, vol. 261, no. 7, pp. 3306–3309, 1986. View at Google Scholar
  18. D. D. Roberts, C. N. Rao, and J. L. Magnani, “Laminin binds specifically to sulfated glycolipids,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 5, pp. 1306–1310, 1985. View at Google Scholar
  19. P. Guchhait, J. A. López, and P. Thiagarajan, “Characterization of autoantibodies against sulfatide from a V-gene phage-display library derived from patients with systemic lupus erythematosus,” Journal of Immunological Methods, vol. 295, no. 1-2, pp. 129–137, 2004. View at Publisher · View at Google Scholar · View at PubMed
  20. P. Guchhait, S. K. Dasgupta, A. Le, S. Yellapragada, J. A. López, and P. Thiagarajan, “Lactadherin mediates sickle cell adhesion to vascular endothelial cells in flowing blood,” Haematologica, vol. 92, no. 9, pp. 1266–1267, 2007. View at Publisher · View at Google Scholar
  21. H. N. Naumann, L. W. Diggs, L. Barreras, and B. J. Williams, “Plasma hemoglobin and hemoglobin fractions in sickle cell crisis,” American Journal of Clinical Pathology, vol. 56, no. 2, pp. 137–147, 1971. View at Google Scholar
  22. C. D. Reiter, X. Wang, J. E. Tanus-Santos, N. Hogg, R. O. Cannon, A. N. Schechter, and M. T. Gladwin, “Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease,” Nature Medicine, vol. 8, no. 12, pp. 1383–1389, 2002. View at Publisher · View at Google Scholar · View at PubMed
  23. Z. Zhou, H. Han, M. A. Cruz, J. A. López, J. F. Dong, and P. Guchhait, “Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease,” Thrombosis and Haemostasis, vol. 101, no. 6, pp. 1070–1077, 2009. View at Publisher · View at Google Scholar
  24. P. Philippidis, J. C. Mason, B. J. Evans, I. Nadra, K. M. Taylor, D. O. Haskard, and R. C. Landis, “Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery,” Circulation Research, vol. 94, no. 1, pp. 119–126, 2004. View at Publisher · View at Google Scholar · View at PubMed
  25. C. A. Schaer, F. Vallelian, A. Imhof, G. Schoedon, and D. J. Schaer, “CD163-expressing monocytes constitute an endotoxin-sensitive Hb clearance compartment within the vascular system,” Journal of Leukocyte Biology, vol. 82, no. 1, pp. 106–110, 2007. View at Publisher · View at Google Scholar · View at PubMed
  26. M. Langlois, J. Delanghe, and M. De Buyzere, “Relation between serum IgA concentration and haptoglobin type,” Clinical Chemistry, vol. 42, no. 10, pp. 1722–1723, 1996. View at Google Scholar
  27. I. A. Tabbara, “Hemolytic anemias: diagnosis and management,” Medical Clinics of North America, vol. 76, no. 3, pp. 649–668, 1992. View at Google Scholar
  28. C. D. Reiter, X. Wang, J. E. Tanus-Santos, N. Hogg, R. O. Cannon, A. N. Schechter, and M. T. Gladwin, “Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease,” Nature Medicine, vol. 8, no. 12, pp. 1383–1389, 2002. View at Publisher · View at Google Scholar · View at PubMed
  29. R. T. Eberhardt, L. McMahon, and L. McMahon, “Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels,” American Journal of Hematology, vol. 74, no. 2, pp. 104–111, 2003. View at Publisher · View at Google Scholar · View at PubMed
  30. K. A. Nath, V. Shah, J. J. Haggard, A. J. Croatt, L. A. Smith, R. P. Hebbel, and Z. S. Katusic, “Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease,” American Journal of Physiology, vol. 279, no. 6, pp. R1949–R1955, 2000. View at Google Scholar
  31. W. Y. Wong, D. Elliott-Mills, and D. Powars, “Renal failure in sickle cell anemia,” Hematology/Oncology Clinics of North America, vol. 10, no. 6, pp. 1321–1331, 1996. View at Google Scholar
  32. J. D. Studt, J. A. Kremer Hovinga, G. Antoine, M. Hermann, M. Rieger, F. Scheiflinger, and B. Lämmle, “Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin,” Blood, vol. 105, no. 2, pp. 542–544, 2005. View at Publisher · View at Google Scholar · View at PubMed
  33. M. W. Radomski, R. M. J. Palmer, and S. Moncada, “Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium,” Lancet, vol. 2, no. 8567, pp. 1057–1058, 1987. View at Google Scholar
  34. Y. Kayanoki, S. Kawata, and S. Kawata, “Reduced nitric oxide production by L-arginine deficiency in lysinuric protein intolerance exacerbates intravascular coagulation,” Metabolism, vol. 48, no. 9, pp. 1136–1140, 1999. View at Publisher · View at Google Scholar
  35. J. Shao, T. Miyata, and T. Miyata, “Protective role of nitric oxide in a model of thrombotic microangiopathy in rats,” Journal of the American Society of Nephrology, vol. 12, no. 10, pp. 2088–2097, 2001. View at Google Scholar
  36. J. J. B. Schnog, J. A. Hovinga, and J. A. Hovinga, “ADAMTS13 activity in sickle cell disease,” American Journal of Hematology, vol. 81, no. 7, pp. 492–498, 2006. View at Publisher · View at Google Scholar · View at PubMed
  37. S. Krishnan, J. Siegel, G. Pullen, M. Hevelow, C. Dampier, and M. Stuart, “Increased von Willebrand factor antigen and high molecular weight multimers in sickle cell disease associated with nocturnal hypoxemia,” Thrombosis Research, vol. 122, no. 4, pp. 455–458, 2008. View at Publisher · View at Google Scholar · View at PubMed
  38. A. C. Makis, E. C. Hatzimichael, and K. L. Bourantas, “The role of cytokines in sickle cell disease,” Annals of Hematology, vol. 79, no. 8, pp. 407–413, 2000. View at Publisher · View at Google Scholar
  39. T. M. Wick, J. L. Moake, M. M. Udden, and L. V. McIntire, “Unusually large von Willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells,” American Journal of Hematology, vol. 42, no. 3, pp. 284–292, 1993. View at Google Scholar
  40. M. Furlan and B. Lämmle, “Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease,” Best Practice and Research: Clinical Haematology, vol. 14, no. 2, pp. 437–454, 2001. View at Publisher · View at Google Scholar · View at PubMed
  41. D. D. Wagner, “Cell biology of von Willebrand factor,” Annual Review of Cell Biology, vol. 6, pp. 217–246, 1990. View at Google Scholar
  42. R. Pendu, V. Terraube, O. D. Christophe, C. G. Gahmberg, P. G. De Groot, P. J. Lenting, and C. V. Denis, “P-selectin glycoprotein ligand 1 and β2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor,” Blood, vol. 108, no. 12, pp. 3746–3752, 2006. View at Publisher · View at Google Scholar · View at PubMed
  43. M. Furlan, R. Rubles, M. Solenthaler, M. Wassmer, P. Sandoz, and B. Lämmle, “Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura,” Blood, vol. 89, no. 9, pp. 3097–3103, 1997. View at Google Scholar
  44. H. M. Tsai and E. C. Y. Lian, “Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura,” New England Journal of Medicine, vol. 339, no. 22, pp. 1585–1594, 1998. View at Publisher · View at Google Scholar · View at PubMed
  45. G. Remuzzi, M. Galbusera, and M. Galbusera, “Von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome,” Blood, vol. 100, no. 3, pp. 778–785, 2002. View at Publisher · View at Google Scholar · View at PubMed
  46. Z. Zhou and P. Guchhait, “Extracellular Hemoglobin regulation of von Willebrand factor activity,” US Hematology. In press.
  47. Q. Zhang, Y. F. Zhou, C. Z. Zhang, X. Zhang, C. Lu, and T. A. Springer, “Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 23, pp. 9226–9231, 2009. View at Publisher · View at Google Scholar · View at PubMed
  48. X. Zhang, K. Halvorsen, C. Z. Zhang, W. P. Wong, and T. A. Springer, “Mechanoenzymatic cleavage of the ultralarge vascular protein von willebrand factor,” Science, vol. 324, no. 5932, pp. 1330–1334, 2009. View at Publisher · View at Google Scholar · View at PubMed